年轻成人静脉血栓栓塞症的特征、治疗与结局:来自RIETE登记研究的结果
基于国际前瞻性RIETE登记研究,截至2022年8月共纳入104253例静脉血栓栓塞症(VTE)患者,其中青少年(12-18岁)234例、年轻成人(18-21岁)884例。年轻成人具有部分独特的VTE危险因素,雌激素使用在青少年和年轻成人中更常见(P<.001),而活动性癌症和制动在两组均不常见;21岁以下患者VTE复发、大出血和全因死亡率均较低,无患者死于VTE复发。
要点
- 年轻成人VTE患者中雌激素使用是常见危险因素,青少年和年轻成人中更常见(P<.001)。
- 青少年和年轻成人中活动性癌症和制动均不常见。
- 青少年和年轻成人VTE复发、大出血和全因死亡率均较低,无21岁以下患者死于VTE复发。
核心结论
- 年轻成人具有部分独特的VTE危险因素;尽管VTE表现可能与年长患者相似,但21岁以下患者的结局更有利。
研究设计与样本
- 前瞻性、国际性RIETE登记研究,截至2022年8月共纳入104253例VTE患者,按年龄分为青少年(12-18岁)234例、年轻成人(18-21岁)884例和年长成人(>21岁)进行比较。
主要发现
- 青少年中报告肺栓塞的病例更少(P<.001)。
- 雌激素使用是常见危险因素,在青少年和年轻成人中更常见(P<.001),而活动性癌症和制动在两组均不常见。
- 大多数患者初始接受低分子量肝素治疗。
- 青少年和年轻成人中VTE复发、大出血和全因死亡率均较低。
- 无21岁以下患者死于VTE复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) is rare in patients aged <21 years. Young adults aged 18 to 21 years are frequently included in adult VTE studies, whereas pediatric VTE studies include patients aged up to either 18 or 21 years. The clinical characteristics of young adult patients with VTE have not been well defined. OBJECTIVES: We aimed to highlight any unique characteristics or treatment considerations that may apply to young adult patients with VTE. METHODS: Data from the prospective, international Registro Informatizado de Enfermedad TromboEmbólica registry were used. Patients were stratified into subcohorts according to age. The clinical characteristics, risk factors, management, and outcomes of young adult patients with VTE were compared with those of adolescents aged 12 to 18 years and adults aged >21 years. RESULTS: Of 104 253 Registro Informatizado de Enfermedad TromboEmbólica patients enrolled until August 2022, 234 were adolescents and 884 were young adults. Less cases of pulmonary embolism were reported in adolescents (P < .001). Estrogen use was a common risk factor, more prevalent in adolescents and young adults (P < .001), whereas active cancer and immobilization were uncommon in both. Most patients were initially treated with low-molecular-weight heparin. VTE recurrence, major bleeding, and all-cause mortality rates were comparably low among adolescents and young adults. None of the patients aged <21 years died from VTE recurrence. CONCLUSION: Young adults have some distinctive VTE risk factors. While VTE presentation may be similar among young adults and older patients, the outcomes of patients aged <21 years are more favorable.
引用
- Cohen O, Barg AA, Nowak-Göttl U, et al. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry. J Thromb Haemost. 2023. PMID: 37406932. doi:10.1016/j.jtha.2023.06.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。